FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133905414> ?p ?o ?g. }

• W3133905414 abstract "Introduction: Corona Virus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. The aim of this study was to investigate the impact of being on an Angiotensin-Converting Enzyme Inhibitors (ACEI) and/or Angiotensin Receptor Blockers (ARB) on hospital admission, on the following COVID-19 outcomes: disease severity, ICU admission, and mortality. Methods: The charts of all patients consecutively diagnosed with COVID-19 from the 24th of February to the 16th of June of the year 2020 in Jaber Al-Ahmed Al-Sabah hospital in Kuwait were checked. All related patient information and clinical data was retrieved from the hospitals electronic medical record system. The primary outcome was COVID-19 disease severity defined as the need for Intensive Care Unit (ICU) admission. Secondary outcome was mortality. Results: A total of 4,019 COVID-19 patients were included, of which 325 patients (8.1%) used ACEI/ARB, users of ACEI/ARB were found to be significantly older (54.4 vs. 40.5 years). ACEI/ARB users were found to have more co-morbidities; diabetes (45.8 vs. 14.8%) and hypertension (92.9 vs. 13.0%). ACEI/ARB use was found to be significantly associated with greater risk of ICU admission in the unadjusted analysis [OR, 1.51 (95% CI: 1.04–2.19), p = 0.028]. After adjustment for age, gender, nationality, coronary artery disease, diabetes and hypertension, ICU admission was found to be inversely associated with ACEI use [OR, 0.57 (95% CI: 0.34–0.88), p = 0.01] and inversely associated with mortality [OR, 0.56 (95% CI: 0.33–0.95), p = 0.032]. Conclusion: The current evidence in the literature supports continuation of ACEI/ARB medications for patients with co-morbidities that acquire COVID-19 infection. Although, the protective effects of such medications on COVID-19 disease severity and mortality remain unclear, the findings of the present study support the use of ACEI/ARB medication." @default.
• W3133905414 created "2021-03-15" @default.
• W3133905414 creator A5004059433 @default.
• W3133905414 creator A5022293501 @default.
• W3133905414 creator A5028634878 @default.
• W3133905414 creator A5044001737 @default.
• W3133905414 creator A5058150043 @default.
• W3133905414 creator A5073200079 @default.
• W3133905414 creator A5076115780 @default.
• W3133905414 creator A5085702404 @default.
• W3133905414 date "2021-03-04" @default.
• W3133905414 modified "2023-10-06" @default.
• W3133905414 title "Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease" @default.
• W3133905414 cites W1964982019 @default.
• W3133905414 cites W1978525739 @default.
• W3133905414 cites W2000040025 @default.
• W3133905414 cites W2025672718 @default.
• W3133905414 cites W2028521865 @default.
• W3133905414 cites W2102184369 @default.
• W3133905414 cites W2129053556 @default.
• W3133905414 cites W2167384912 @default.
• W3133905414 cites W3001118548 @default.
• W3133905414 cites W3004280078 @default.
• W3133905414 cites W3008767470 @default.
• W3133905414 cites W3009799538 @default.
• W3133905414 cites W3009885589 @default.
• W3133905414 cites W3011605790 @default.
• W3133905414 cites W3012180666 @default.
• W3133905414 cites W3012184818 @default.
• W3133905414 cites W3012285389 @default.
• W3133905414 cites W3012320055 @default.
• W3133905414 cites W3013302817 @default.
• W3133905414 cites W3013334176 @default.
• W3133905414 cites W3017490556 @default.
• W3133905414 cites W3017545174 @default.
• W3133905414 cites W3023751598 @default.
• W3133905414 cites W3024575398 @default.
• W3133905414 cites W3028967077 @default.
• W3133905414 cites W3030177929 @default.
• W3133905414 cites W3033263367 @default.
• W3133905414 cites W3034110780 @default.
• W3133905414 cites W3035819488 @default.
• W3133905414 cites W3037545893 @default.
• W3133905414 cites W3037784930 @default.
• W3133905414 cites W3038411417 @default.
• W3133905414 cites W3084139336 @default.
• W3133905414 cites W3085721524 @default.
• W3133905414 cites W3093398083 @default.
• W3133905414 cites W3165656738 @default.
• W3133905414 doi "https://doi.org/10.3389/fmed.2021.600385" @default.
• W3133905414 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7969499" @default.
• W3133905414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33748156" @default.
• W3133905414 hasPublicationYear "2021" @default.
• W3133905414 type Work @default.
• W3133905414 sameAs 3133905414 @default.
• W3133905414 citedByCount "11" @default.
• W3133905414 countsByYear W31339054142021 @default.
• W3133905414 countsByYear W31339054142022 @default.
• W3133905414 countsByYear W31339054142023 @default.
• W3133905414 crossrefType "journal-article" @default.
• W3133905414 hasAuthorship W3133905414A5004059433 @default.
• W3133905414 hasAuthorship W3133905414A5022293501 @default.
• W3133905414 hasAuthorship W3133905414A5028634878 @default.
• W3133905414 hasAuthorship W3133905414A5044001737 @default.
• W3133905414 hasAuthorship W3133905414A5058150043 @default.
• W3133905414 hasAuthorship W3133905414A5073200079 @default.
• W3133905414 hasAuthorship W3133905414A5076115780 @default.
• W3133905414 hasAuthorship W3133905414A5085702404 @default.
• W3133905414 hasBestOaLocation W31339054141 @default.
• W3133905414 hasConcept C126322002 @default.
• W3133905414 hasConcept C134018914 @default.
• W3133905414 hasConcept C194828623 @default.
• W3133905414 hasConcept C27016395 @default.
• W3133905414 hasConcept C2776376669 @default.
• W3133905414 hasConcept C2779134260 @default.
• W3133905414 hasConcept C2910553456 @default.
• W3133905414 hasConcept C3008058167 @default.
• W3133905414 hasConcept C524204448 @default.
• W3133905414 hasConcept C555293320 @default.
• W3133905414 hasConcept C71924100 @default.
• W3133905414 hasConcept C84393581 @default.
• W3133905414 hasConceptScore W3133905414C126322002 @default.
• W3133905414 hasConceptScore W3133905414C134018914 @default.
• W3133905414 hasConceptScore W3133905414C194828623 @default.
• W3133905414 hasConceptScore W3133905414C27016395 @default.
• W3133905414 hasConceptScore W3133905414C2776376669 @default.
• W3133905414 hasConceptScore W3133905414C2779134260 @default.
• W3133905414 hasConceptScore W3133905414C2910553456 @default.
• W3133905414 hasConceptScore W3133905414C3008058167 @default.
• W3133905414 hasConceptScore W3133905414C524204448 @default.
• W3133905414 hasConceptScore W3133905414C555293320 @default.
• W3133905414 hasConceptScore W3133905414C71924100 @default.
• W3133905414 hasConceptScore W3133905414C84393581 @default.
• W3133905414 hasFunder F4320321818 @default.
• W3133905414 hasLocation W31339054141 @default.
• W3133905414 hasLocation W31339054142 @default.
• W3133905414 hasOpenAccess W3133905414 @default.
• W3133905414 hasPrimaryLocation W31339054141 @default.
• W3133905414 hasRelatedWork W1563850031 @default.
• W3133905414 hasRelatedWork W1988667767 @default.

• next